198 related articles for article (PubMed ID: 10885422)
1. MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients.
Viglio S; Iadarola P; Lupi A; Trisolini R; Tinelli C; Balbi B; Grassi V; Worlitzsch D; Döring G; Meloni F; Meyer KC; Dowson L; Hill SL; Stockley RA; Luisetti M
Eur Respir J; 2000 Jun; 15(6):1039-45. PubMed ID: 10885422
[TBL] [Abstract][Full Text] [Related]
2. Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosis.
Bode DC; Pagani ED; Cumiskey WR; von Roemeling R; Hamel L; Silver PJ
Pulm Pharmacol Ther; 2000; 13(4):175-80. PubMed ID: 10930356
[TBL] [Abstract][Full Text] [Related]
3. Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease.
Viglio S; Zanaboni G; Luisetti M; Trisolini R; Grimm R; Cetta G; Iadarola P
J Chromatogr B Biomed Sci Appl; 1998 Aug; 714(1):87-98. PubMed ID: 9746238
[TBL] [Abstract][Full Text] [Related]
4. Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.
Fregonese L; Ferrari F; Fumagalli M; Luisetti M; Stolk J; Iadarola P
COPD; 2011 Oct; 8(5):329-33. PubMed ID: 21793711
[TBL] [Abstract][Full Text] [Related]
5. Measurements of desmosine and isodesmosine by mass spectrometry in COPD.
Ma S; Lin YY; Turino GM
Chest; 2007 May; 131(5):1363-71. PubMed ID: 17494786
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation.
Ma S; Turino GM; Lin YY
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1893-8. PubMed ID: 21621489
[TBL] [Abstract][Full Text] [Related]
7. Desmosine radioimmunoassay for measuring elastin degradation in vivo.
Harel S; Janoff A; Yu SY; Hurewitz A; Bergofsky EH
Am Rev Respir Dis; 1980 Nov; 122(5):769-73. PubMed ID: 7447157
[TBL] [Abstract][Full Text] [Related]
8. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions.
Luisetti M; Ma S; Iadarola P; Stone PJ; Viglio S; Casado B; Lin YY; Snider GL; Turino GM
Eur Respir J; 2008 Nov; 32(5):1146-57. PubMed ID: 18978133
[TBL] [Abstract][Full Text] [Related]
9. Development of a robust LC-MS/MS method for determination of desmosine and isodesmosine in human urine.
Shiraishi K; Matsuzaki K; Matsumoto A; Hashimoto Y; Iba K
J Oleo Sci; 2010; 59(8):431-9. PubMed ID: 20625235
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin-deficient humans.
Stone PJ; Morris TA; Franzblau C; Snider GL
Respiration; 1995; 62(2):76-9. PubMed ID: 7784713
[TBL] [Abstract][Full Text] [Related]
11. Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD.
Kim C; Ko Y; Kim SH; Yoo HJ; Lee JS; Rhee CK; Lee JH; Lee JH; Kim TH; Lim SY; Yoo KH; Seo JB; Oh YM; Lee SD; Park YB
Respirology; 2018 Feb; 23(2):176-181. PubMed ID: 28905464
[TBL] [Abstract][Full Text] [Related]
12. Determination of free desmosine and isodesmosine as urinary biomarkers of lung disorder using ultra performance liquid chromatography-ion mobility-mass spectrometry.
Devenport NA; Reynolds JC; Parkash V; Cook J; Weston DJ; Creaser CS
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3797-801. PubMed ID: 22088351
[TBL] [Abstract][Full Text] [Related]
13. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease.
Stone PJ; Gottlieb DJ; O'Connor GT; Ciccolella DE; Breuer R; Bryan-Rhadfi J; Shaw HA; Franzblau C; Snider GL
Am J Respir Crit Care Med; 1995 Apr; 151(4):952-9. PubMed ID: 7697272
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
Turino GM; Ma S; Cantor JO; Lin YY
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S336-40. PubMed ID: 27564670
[TBL] [Abstract][Full Text] [Related]
15. Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report.
Fiorenza D; Viglio S; Lupi A; Baccheschi J; Tinelli C; Trisolini R; Iadarola R; Luisetti M; Snider GL
Respir Med; 2002 Feb; 96(2):110-4. PubMed ID: 11860167
[TBL] [Abstract][Full Text] [Related]
16. Enrichment and analysis of desmosine and isodesmosine in biological fluids.
Cumiskey WR; Pagani ED; Bode DC
J Chromatogr B Biomed Appl; 1995 Jun; 668(2):199-207. PubMed ID: 7581855
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of desmosine (elastin cross-links) in subjects with PiZZ alpha-1-antitrypsin deficiency, a phenotype associated with hereditary predisposition to pulmonary emphysema.
Pelham F; Wewers M; Crystal R; Buist AS; Janoff A
Am Rev Respir Dis; 1985 Oct; 132(4):821-3. PubMed ID: 3876794
[TBL] [Abstract][Full Text] [Related]
18. Elastin and collagen degradation products in urine of patients with cystic fibrosis.
Stone PJ; Konstan MW; Berger M; Dorkin HL; Franzblau C; Snider GL
Am J Respir Crit Care Med; 1995 Jul; 152(1):157-62. PubMed ID: 7599816
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine.
Boutin M; Berthelette C; Gervais FG; Scholand MB; Hoidal J; Leppert MF; Bateman KP; Thibault P
Anal Chem; 2009 Mar; 81(5):1881-7. PubMed ID: 19178285
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic Chichibabin pyridine synthesis of the COPD biomarkers and elastin cross-linkers isodesmosine and desmosine.
Usuki T; Sugimura T; Komatsu A; Koseki Y
Org Lett; 2014 Mar; 16(6):1672-5. PubMed ID: 24597689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
